ARTICLE | Company News
Medigene, Sinphar Pharmaceutical sales and marketing update
October 14, 2013 7:00 AM UTC
SynCore Biotechnology Co. Ltd., a JV between Sinphar and the National Health Research Institute of Taiwan (Taipei, Taiwan), launched Veregen sinecatechins in Taiwan to treat genital warts. Medigene said Taiwan is the first Asian country in which Veregen has been launched. The company did not provide pricing information in time for publication. ...